Skip to main content

Table 1 Patient characteristics

From: Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud’s Phenomenon

Variable

No RP

Primary RP

Secondary RP [subset with antibody or red flag feature]

SSc

All patients

Number, n (%)

54 (15.6)

69 (19.9)

172 (49.6)

[101 (29.1)]

52 (15.0)

347 (100)

Age, years, mean (SD)

42.2 (14.6)

40.6 (13.9)

47.4 (14.0)

[45.3 (14.8)]

58.8 (14.4)

47 (15.2)

Female

47 (87)

51 (74)

145 (84)

[86 (85)]

45 (87)

288 (83)

Duration of RP, months, median (IQR)

-

61.0 (24.0, 149.0)

(n = 64)

57 (18.0, 160.0)

[60 (24.0, 180.0)]

(n = 154 [94])

70.0 (30.0, 240.0)

(n = 47)

60.0 (24.0, 166.0)

(n = 265)

Current smokers, n (%)

9/41 (22)

17/57 (30)

40/146 (27)

[22/87 (25)]

7/42 (17)

73/286(26)

Ab positive, n (%)

33 (61)

0 (0)

145 (84)

[91 (90)]

48 (92)

226 (65)

ANA positive, n (%)

32 (59)

0 (0)

142 (83)

[88 (87)]

48 (92)

222 (64)

ACA positive, n (%)

4 (7)

0 (0)

20 (12)

[12 (12)]

29 (56)

53 (15)

Scl-70 positive, n (%)

3 (6)

0 (0)

7 (4)

[3 (3)]

4 (8)

14 (4)

  1. Ab antibody, ACA anti-centromere antibody, ANA antinuclear antibody, IQR inter-quartile range, N number, RP Raynaud’s Phenomenon, Scl-70 anti-topoisomerase antibody, SD standard deviation, SSc Systemic Sclerosis